This is particularly important since our IHC data indicate that over 30% of stomach adenocarcinoma (STAD) are negative for DUOX2 and an analysis of the TCGA database indicates that DUOX2 mRNA is not upregulated in STAD (Figure 5 and Figure 6). Here, DUOX2 is linked to gastric adenocarcinoma.